Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer’s disease
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 8, Issue 1, Pages 259-265
Publisher
Wiley
Online
2020-11-30
DOI
10.1002/acn3.51253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets
- (2018) Carles Falcon et al. NeuroImage-Clinical
- Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI
- (2016) Susan M. Landau et al. NEUROLOGY
- Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
- (2015) Clifford R. Jack et al. BRAIN
- Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease
- (2015) Rawan Tarawneh et al. JAMA Neurology
- Biological heterogeneity in ADNI amnestic mild cognitive impairment
- (2014) Jasmine Nettiksimmons et al. Alzheimers & Dementia
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Cerebrospinal Fluid Proteins Predict Longitudinal Hippocampal Degeneration in Early-stage Dementia of the Alzheimer Type
- (2011) Lei Wang et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
- (2009) R. C. Petersen et al. NEUROLOGY
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
- (2008) Clifford R. Jack et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started